Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 (COMET-PEAK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04779879
Recruitment Status : Completed
First Posted : March 3, 2021
Last Update Posted : April 27, 2022
Information provided by (Responsible Party):
Vir Biotechnology, Inc.